Roles of CREB in the regulation of FMRP by group i metabotropic glutamate receptors in cingulate cortex

Molecular Brain

Volumn 5, Issue 1, 2012, Pages

  Wang, Hansen ^a   Morishita, Yoshikazu ^b   Miura, Daiki ^b   Naranjo, Jose R ^c   Kida, Satoshi ^b   Zhuo, Min ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b TOKYO UNIVERSITY OF AGRICULTURE   (Japan)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Cingulate cortex; CREB; FMRP; Fragile X syndrome; Gene expression; Group I mGluRs

Indexed keywords

3,5 DIHYDROXYPHENYLGLYCINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; CALSENILIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; METABOTROPIC RECEPTOR 1;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; CALCIUM CELL LEVEL; CINGULATE GYRUS; COGNITION; CONTROLLED STUDY; EXECUTIVE FUNCTION; GENETIC TRANSCRIPTION; MALE; MEMORY CONSOLIDATION; MENTAL PERFORMANCE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; UPREGULATION;

ANIMALS; BASE SEQUENCE; CALCIUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FRAGILE X MENTAL RETARDATION PROTEIN; GENES, DOMINANT; GYRUS CINGULI; KV CHANNEL-INTERACTING PROTEINS; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NEURONS; PROMOTER REGIONS, GENETIC; RECEPTORS, METABOTROPIC GLUTAMATE; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION;

MUS;

EID: 84864506400     PISSN: None     EISSN: 17566606     Source Type: Journal    
DOI: 10.1186/1756-6606-5-27     Document Type: Review

References (59)

1. Fragile X syndrome and autism at the intersection of genetic and neural networks. Belmonte MK, Bourgeron T, Nat Neurosci 2006 9 10 1221 1225 10.1038/nn1765 17001341 (Pubitemid 44454259)
2. The Pathophysiology of Fragile X (and What It Teaches Us about Synapses). Bhakar AL, Dolen G, Bear MF, Annu Rev Neurosci 2012 2012 2012
3. Translational suppression by trinucleotide repeat expansion at FMR1. Feng Y, Zhang F, Lokey LK, Chastain JL, Lakkis L, Eberhart D, Warren ST, Science 1995 268 5211 731 734 10.1126/science.7732383 7732383
4. Fragile X syndrome. Garber KB, Visootsak J, Warren ST, Eur J Hum Genet 2008 16 6 666 672 10.1038/ejhg.2008.61 18398441 (Pubitemid 351753362)
5. Fragile X syndrome: molecular mechanisms of cognitive dysfunction. Huber K, Am J Psychiatry 2007 164 4 556 10.1176/appi.ajp.164.4.556 17403966 (Pubitemid 46650183)
6. New insights into fragile X syndrome: from molecules to neurobehaviors. Jin P, Warren ST, Trends Biochem Sci 2003 28 3 152 158 10.1016/S0968-0004(03) 00033-1 12633995 (Pubitemid 36293853)
7. Molecular mechanisms of fragile X syndrome: a twenty-year perspective. Santoro MR, Bray SM, Warren ST, Annu Rev Pathol 2011 7 219 245 22017584
8. Toward fulfilling the promise of molecular medicine in fragile X syndrome. Krueger DD, Bear MF, Annu Rev Med 2011 62 411 429 10.1146/annurev-med- 061109-134644 21090964
9. New perspectives on the biology of fragile X syndrome. Wang T, Bray SM, Warren ST, Curr Opin Genet Dev 2012 22 3 256 263 10.1016/j.gde.2012.02.002 22382129
10. From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome. Bagni C, Greenough WT, Nat Rev Neurosci 2005 6 5 376 387 15861180 (Pubitemid 40593483)
11. Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Bassell GJ, Warren ST, Neuron 2008 60 2 201 214 10.1016/j.neuron.2008.10.004 18957214
12. Purified recombinant Fmrp exhibits selective RNA binding as an intrinsic property of the fragile X mental retardation protein. Brown V, Small K, Lakkis L, Feng Y, Gunter C, Wilkinson KD, Warren ST, J Biol Chem 1998 273 25 15521 15527 10.1074/jbc.273.25.15521 9624140 (Pubitemid 28298162)
13. Translational control of long-lasting synaptic plasticity and memory. Costa-Mattioli M, Sossin WS, Klann E, Sonenberg N, Neuron 2009 61 1 10 26 10.1016/j.neuron.2008.10.055 19146809
14. Translational regulation of the human achaete-scute homologue-1 by fragile X mental retardation protein. Fahling M, Mrowka R, Steege A, Kirschner KM, Benko E, Forstera B, Persson PB, Thiele BJ, Meier JC, Scholz H, J Biol Chem 2009 284 7 4255 4266 19097999
15. Synaptic regulation of protein synthesis and the fragile X protein. Greenough WT, Klintsova AY, Irwin SA, Galvez R, Bates KE, Weiler IJ, Proc Natl Acad Sci U S A 2001 98 13 7101 7106 10.1073/pnas.141145998 11416194 (Pubitemid 32567909)
16. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Huber KM, Gallagher SM, Warren ST, Bear MF, Proc Natl Acad Sci U S A 2002 99 11 7746 7750 10.1073/pnas.122205699 12032354 (Pubitemid 34568762)
17. The mGluR theory of fragile X mental retardation. Bear MF, Huber KM, Warren ST, Trends Neurosci 2004 27 7 370 377 10.1016/j.tins.2004.04.009 15219735 (Pubitemid 38829251)
18. Local protein synthesis and spine morphogenesis: Fragile X syndrome and beyond. Grossman AW, Aldridge GM, Weiler IJ, Greenough WT, J Neurosci 2006 26 27 7151 7155 10.1523/JNEUROSCI.1790-06.2006 16822971
19. Altered mRNA transport, docking, and protein translation in neurons lacking fragile X mental retardation protein. Kao DI, Aldridge GM, Weiler IJ, Greenough WT, Proc Natl Acad Sci U S A 2010 107 35 15601 15606 10.1073/pnas.1010564107 20713728
20. Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond. Gross C, Berry-Kravis EM, Bassell GJ, Neuropsychopharmacology 2012 37 1 178 195 10.1038/npp.2011.137 21796106
21. Dynamic translational and proteasomal regulation of fragile X mental retardation protein controls mGluR-dependent long-term depression. Hou L, Antion MD, Hu D, Spencer CM, Paylor R, Klann E, Neuron 2006 51 4 441 454 10.1016/j.neuron.2006.07.005 16908410 (Pubitemid 44189802)
22. Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors. Nakamoto M, Nalavadi V, Epstein MP, Narayanan U, Bassell GJ, Warren ST, Proc Natl Acad Sci U S A 2007 104 39 15537 15542 10.1073/pnas.0707484104 17881561 (Pubitemid 47502952)
23. Hypersensitivity to mGluR5 and ERK1/2 leads to excessive protein synthesis in the hippocampus of a mouse model of fragile X syndrome. Osterweil EK, Krueger DD, Reinhold K, Bear MF, J Neurosci 2010 30 46 15616 15627 10.1523/JNEUROSCI.3888-10.2010 21084617
24. Making synaptic plasticity and memory last: mechanisms of translational regulation. Richter JD, Klann E, Genes Dev 2009 23 1 1 11 10.1101/gad.1735809 19136621
25. FMRP acts as a key messenger for dopamine modulation in the forebrain. Wang H, Wu LJ, Kim SS, Lee FJ, Gong B, Toyoda H, Ren M, Shang YZ, Xu H, Liu F, et al. Neuron 2008 59 4 634 647 10.1016/j.neuron.2008.06.027 18760699
26. Identification of an adenylyl cyclase inhibitor for treating neuropathic and inflammatory pain. Wang H, Xu H, Wu LJ, Kim SS, Chen T, Koga K, Descalzi G, Gong B, Vadakkan KI, Zhang X, et al. Sci Transl Med 2011 3 65 65 63
27. Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. Zhao MG, Toyoda H, Ko SW, Ding HK, Wu LJ, Zhuo M, J Neurosci 2005 25 32 7385 7392 10.1523/JNEUROSCI.1520-05.2005 16093389 (Pubitemid 41129811)
28. Molecular mechanisms of pain in the anterior cingulate cortex. Zhuo M, J Neurosci Res 2006 84 5 927 933 10.1002/jnr.21003 16862566 (Pubitemid 44521036)
29. Cortical excitation and chronic pain. Zhuo M, Trends Neurosci 2008 31 4 199 207 10.1016/j.tins.2008.01.003 18329111
30. Trace but not delay fear conditioning requires attention and the anterior cingulate cortex. Han CJ, OTuathaigh CM, van Trigt L, Quinn JJ, Fanselow MS, Mongeau R, Koch C, Anderson DJ, Proc Natl Acad Sci U S A 2003 100 22 13087 13092 10.1073/pnas.2132313100 14555761 (Pubitemid 37340030)
31. The involvement of the anterior cingulate cortex in remote contextual fear memory. Frankland PW, Bontempi B, Talton LE, Kaczmarek L, Silva AJ, Science 2004 304 5672 881 883 10.1126/science.1094804 15131309 (Pubitemid 38620189)
32. Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S, Proc Natl Acad Sci U S A 2007 104 27 11489 11494 10.1073/pnas.0705003104 17592139 (Pubitemid 47175167)
33. Pavlovian fear memory induced by activation in the anterior cingulate cortex. Tang J, Ko S, Ding HK, Qiu CS, Calejesan AA, Zhuo M, Mol Pain 2005 1 1 6 10.1186/1744-8069-1-6 15813993 (Pubitemid 44848615)
34. Loss of synaptic depression in mammalian anterior cingulate cortex after amputation. Wei F, Li P, Zhuo M, J Neurosci 1999 19 21 9346 9354 10531439 (Pubitemid 30228088)
35. Fragile X mental retardation protein is necessary for neurotransmitter-activated protein translation at synapses. Weiler IJ, Spangler CC, Klintsova AY, Grossman AW, Kim SH, Bertaina-Anglade V, Khaliq H, de Vries FE, Lambers FA, Hatia F, et al. Proc Natl Acad Sci U S A 2004 101 50 17504 17509 10.1073/pnas.0407533101 15548614 (Pubitemid 39657433)
36. Metabotropic receptor-dependent long-term depression persists in the absence of protein synthesis in the mouse model of fragile X syndrome. Nosyreva ED, Huber KM, J Neurophysiol 2006 95 5 3291 3295 10.1152/jn.01316.2005 16452252
37. Ca2+/calmodulin-dependent protein kinase IV links group I metabotropic glutamate receptors to fragile X mental retardation protein in cingulate cortex. Wang H, Fukushima H, Kida S, Zhuo M, J Biol Chem 2009 284 28 18953 18962 10.1074/jbc.M109.019141 19436069
38. Roles of calcium-stimulated adenylyl cyclase and calmodulin-dependent protein kinase IV in the regulation of FMRP by group I metabotropic glutamate receptors. Wang H, Wu LJ, Zhang F, Zhuo M, J Neurosci 2008 28 17 4385 4397 10.1523/JNEUROSCI.0646-08.2008 18434517
39. CREB activity maintains the survival of cingulate cortical pyramidal neurons in the adult mouse brain. Ao H, Ko SW, Zhuo M, Mol Pain 2006 2 15 10.1186/1744-8069-2-15 16640787
40. Gene expression profiling of facilitated L-LTP in VP16-CREB mice reveals that BDNF is critical for the maintenance of LTP and its synaptic capture. Barco A, Patterson SL, Alarcon JM, Gromova P, Mata-Roig M, Morozov A, Kandel ER, Neuron 2005 48 1 123 137 10.1016/j.neuron.2005.09.005 16202713 (Pubitemid 41384170)
41. Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders. Hardingham GE, Bading H, Nat Rev Neurosci 2010 11 10 682 696 10.1038/nrn2911 20842175
42. Function and regulation of CREB family transcription factors in the nervous system. Lonze BE, Ginty DD, Neuron 2002 35 4 605 623 10.1016/S0896-6273(02)00828-0 12194863 (Pubitemid 35229980)
43. Genetic evidence for adenylyl cyclase 1 as a target for preventing neuronal excitotoxicity mediated by N-methyl-D-aspartate receptors. Wang H, Gong B, Vadakkan KI, Toyoda H, Kaang BK, Zhuo M, J Biol Chem 2007 282 2 1507 1517 17121841 (Pubitemid 47076580)
44. Ca(V)1 and Ca(V)2 Channels Engage Distinct Modes of Ca(2+) Signaling to Control CREB-Dependent Gene Expression. Wheeler DG, Groth RD, Ma H, Barrett CF, Owen SF, Safa P, Tsien RW, Cell 2012 149 5 1112 1124 10.1016/j.cell.2012.03.041 22632974
45. Activity-dependent CREB phosphorylation: convergence of a fast, sensitive calmodulin kinase pathway and a slow, less sensitive mitogen-activated protein kinase pathway. Wu GY, Deisseroth K, Tsien RW, Proc Natl Acad Sci U S A 2001 98 5 2808 2813 10.1073/pnas.051634198 11226322 (Pubitemid 32209565)
46. Characterization of a CREB gain-of-function mutant with constitutive transcriptional activity in vivo. Du K, Asahara H, Jhala US, Wagner BL, Montminy M, Mol Cell Biol 2000 20 12 4320 4327 10.1128/MCB.20.12.4320-4327.2000 10825195 (Pubitemid 30346626)
47. Upregulation of CREB-Mediated Transcription Enhances Both Short- and Long-Term Memory. Suzuki A, Fukushima H, Mukawa T, Toyoda H, Wu LJ, Zhao MG, Xu H, Shang Y, Endoh K, Iwamoto T, et al. J Neurosci 2011 31 24 8786 8802 10.1523/JNEUROSCI.3257-10.2011 21677163
48. The role of calsenilin/DREAM/KChIP3 in contextual fear conditioning. Alexander JC, McDermott CM, Tunur T, Rands V, Stelly C, Karhson D, Bowlby MR, An WF, Sweatt JD, Schrader LA, Learn Mem 2009 16 3 167 177 10.1101/lm.1261709 19223600
49. Downstream regulatory element antagonist modulator regulates Ca2+ homeostasis and viability in cerebellar neurons. Gomez-Villafuertes R, Torres B, Barrio J, Savignac M, Gabellini N, Rizzato F, Pintado B, Gutierrez-Adan A, Mellstrom B, Carafoli E, et al. J Neurosci 2005 25 47 10822 10830 10.1523/JNEUROSCI.3912-05.2005 16306395 (Pubitemid 41692612)
50. DREAM (downstream regulatory element antagonist modulator) contributes to synaptic depression and contextual fear memory. Wu LJ, Mellstrom B, Wang H, Ren M, Domingo S, Kim SS, Li XY, Chen T, Naranjo JR, Zhuo M, Mol Brain 2010 3 3 10.1186/1756-6606-3-3 20205763
51. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Shaywitz AJ, Greenberg ME, Annu Rev Biochem 1999 68 821 861 10.1146/annurev.biochem.68.1.821 10872467 (Pubitemid 29449210)
52. The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB. Kandel ER, Mol Brain 2012 5 1 14 10.1186/1756-6606-5-14 22583753
53. FMR1 enhancer is regulated by cAMP through a cAMP-responsive element. Hwu WL, Wang TR, Lee YM, DNA Cell Biol 1997 16 4 449 453 10.1089/dna.1997.16.449 9150432
54. The gene encoding the fragile X RNA-binding protein is controlled by nuclear respiratory factor 2 and the CREB family of transcription factors. Smith KT, Nicholls RD, Reines D, Nucleic Acids Res 2006 34 4 1205 1215 10.1093/nar/gkj521 16500891
55. CREBs control of intrinsic and synaptic plasticity: implications for CREB-dependent memory models. Benito E, Barco A, Trends Neurosci 2010 33 5 230 240 10.1016/j.tins.2010.02.001 20223527
56. Ca2+dependent block of CREB-CBP transcription by repressor DREAM. Ledo F, Kremer L, Mellstrom B, Naranjo JR, Embo J 2002 21 17 4583 4592 10.1093/emboj/cdf440 12198160 (Pubitemid 34984345)
57. Roles of fragile X mental retardation protein in dopaminergic stimulation-induced synapse-associated protein synthesis and subsequent alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-4-propionate (AMPA) receptor internalization. Wang H, Kim SS, Zhuo M, J Biol Chem 2010 285 28 21888 21901 10.1074/jbc.M110.116293 20457613
58. DREAM regulates BDNF-dependent spinal sensitization. Rivera-Arconada I, Benedet T, Roza C, Torres B, Barrio J, Krzyzanowska A, Avendano C, Mellstrom B, Lopez-Garcia JA, Naranjo JR, Mol Pain 2010 6 95 10.1186/1744-8069-6-95 21167062
59. Transcriptional repressor DREAM regulates T-lymphocyte proliferation and cytokine gene expression. Savignac M, Pintado B, Gutierrez-Adan A, Palczewska M, Mellstrom B, Naranjo JR, Embo J 2005 24 20 3555 3564 10.1038/sj.emboj.7600810 16177826 (Pubitemid 41509363)